Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Ocuphire Pharma Inc.

Start price
Target price
Perf. (%)
€5.00
30.06.21
€8.00
30.06.22
-22.40%
09.07.21

Could be worthwhile Investment >10% per year
Good culture
Little innovation
me8 
30.06.21 0%
buy
Veeva Systems A

Start price
Target price
Perf. (%)
€269.00
29.06.21
€275.00
29.06.22
-29.38%
29.06.22

Top 10 in its market
Could be worthwhile Investment >10% per year
Innovative
Some uniques
tbackenh 
29.06.21 60%
sell
Abivax S.A.

Start price
Target price
Perf. (%)
€30.50
28.06.21
€25.00
28.06.22
-16.39%
01.12.21

Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
Snowman 
28.06.21 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€51.63
28.06.21
€58.00
18.01.23
10.09%
18.01.23

Undervalued
Well known brand
Future proof or reliable business model
Top 10 in its market
Snowman 
28.06.21 60%
buy
Pra Health

Start price
Target price
Perf. (%)
€141.00
28.06.21
€200.00
28.06.22
-0.71%
12.07.21

Could be worthwhile Investment >10% per year
DomRuinart 
28.06.21 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€72.60
28.06.21
€120.00
28.06.22
-21.07%
12.07.21

Could be worthwhile Investment >10% per year
DomRuinart 
28.06.21 50%
buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€146.55
28.06.21
€200.00
28.06.22
-3.62%
12.07.21

Could be worthwhile Investment >10% per year
DomRuinart 
28.06.21 50%
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€48.00
28.06.21
€75.00
28.06.22
-2.98%
12.07.21

Fair valuation
Good rating
Normal challenges to pay loans and raise capital
Leading role in innovation
DomRuinart 
28.06.21 50%
buy
Syros Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€46.00
26.06.21
-
26.06.22
-81.82%
27.06.22

Could be very worthwhile Investment >20% year
skyrockerZoe 
26.06.21 0%
sell
Osmotica Pharmaceuticals PLC

Start price
Target price
Perf. (%)
€3.04
26.06.21
€1.00
26.06.22
-18.42%
10.07.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
nvestor 
26.06.21 50%
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€7.20
25.06.21
-
25.06.22
-26.39%
30.06.21

Could be very worthwhile Investment >20% year
daimler1 
25.06.21 50%
sell
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€16.08
24.06.21
€4.80
24.06.22
-60.12%
20.12.21

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
geldnutzer 
24.06.21 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€37.08
21.06.21
-
21.06.22
4.91%
29.06.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Fair valuation
High Investments for future growth
Mori8 
21.06.21 50%
buy
QIAGEN NV

Start price
Target price
Perf. (%)
€39.90
21.06.21
-
21.06.22
19.05%
27.08.21

Could be worthwhile Investment >10% per year
ROE higher than 10% per year
Little Investments for future growth
Mori8 
21.06.21 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€52.02
21.06.21
-
21.06.22
-2.25%
06.07.21

Mori8 
21.06.21 50%
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€47.92
19.06.21
€58.00
19.06.22
-20.72%
27.12.21

Could be worthwhile Investment >10% per year
melinda 
19.06.21 50%
buy
Sartorius AG VZO

Start price
Target price
Perf. (%)
€413.70
18.06.21
€600.00
18.06.22
35.75%
27.09.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Good rating
High valuation
tbackenh 
18.06.21 95%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€158.36
17.06.21
€165.00
17.06.22
59.60%
18.06.22

Could be worthwhile Investment >10% per year
melinda 
17.06.21 50%
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€11.37
17.06.21
€18.00
09.03.22
95.60%
10.03.22

Could be very worthwhile Investment >20% year
melinda 
17.06.21 40%
sell
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€53.25
17.06.21
-
09.03.22
-
17.06.21

Could be very worthwhile Investment >20% year
melinda 
17.06.21 0%
buy
co.don AG

Start price
Target price
Perf. (%)
€1.41
17.06.21
-
17.06.23
-13.17%
17.06.23

Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Maxi_Scalibusa 
17.06.21 0%
buy
GSK plc

Start price
Target price
Perf. (%)
€16.86
17.06.21
-
17.06.25
0.47%
05.07.21

Small cyclical dependencies
Could be worthwhile Investment >10% per year
Gilbert 
17.06.21 50%
sell
Valneva SE

Start price
Target price
Perf. (%)
€10.89
17.06.21
€8.00
17.06.22
3.21%
20.07.21

Could be worthwhile Investment >10% per year
Very valuable balance sheet
melinda 
17.06.21 50%
sell
Avid Bioservices Inc

Start price
Target price
Perf. (%)
€20.60
17.06.21
€17.00
17.06.22
38.84%
26.11.21

Could be worthwhile Investment >10% per year
melinda 
17.06.21 50%
sell
Carisma Therapeutics Inc.

Start price
Target price
Perf. (%)
€73.80
17.06.21
€50.00
17.06.22
-66.50%
17.08.21

Could be worthwhile Investment >10% per year
melinda 
17.06.21 50%